Category: CovidienSyndicate content

Medtronic issues update on debt financing before Covidien merger | Medtech Wall Street news for the week of October 27, 2014

October 30, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Medtronic updates on $43B Covidien deal financing; Boston Scientific, Bard CEOs cool on consolidation; Nevro sets range for IPO of up to $106m; Alere to sell Alere Health unit to Optum for $600m; Skyline Medical conducts 1-for-75 reverse stock split

Medtronic updates on $43B Covidien deal financing

October 24, 2014 by Brad Perriello

Medtronic, Covidien merger expected to close in 2015

October 30, 2014 by Brad Perriello

Medtronic and Covidien say their pending, $43 billion merger is expected to close in early 2015.

Medtronic, Covidien merger expected to close in 2015

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

COV will likely divest some vascular therapies ahead of MDT merger | The week in medtech M&A

October 29, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Covidien plans to sell some vascular therapies ahead of Medtronic merger; Covidien, Medtronic shares jump on affirmation of $43B merger; Wright Medical to acquire Tornier for $3.3B in inversion deal; Integra LifeSciences closes MicroFrance, Xomed buy from Medtronic; Globus Medical snaps up allograft maker Transplant Technologies

Covidien plans to sell some vascular therapies ahead of Medtronic merger

October 24, 2014 by Brad Perriello

Covidien unveils next-gen superDimension device

October 27, 2014 by Brad Perriello

Covidien unveils the next generation of its superDimension device for lung imaging procedures.

Covidien unveils next-gen superDimension device

Covidien (NYSE:COV) today unveiled the next generation of its superDimension navigation software for lung procedures.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien plans to sell some vascular therapies ahead of Medtronic merger

October 24, 2014 by Brad Perriello

Covidien says it plans to divest its some of its vascular therapies business to mollify U.S. anti-trust regulators about its proposed $43 billion merger with Medtronic.

Covidien plans to sell some vascular therapies ahead of Medtronic merger

Medtech's betting on the GOP in midterm elections

October 24, 2014 by Brian Johnson

A look at the top 10 politicial action committee donations shows that medtech is betting heavily on a GOP win in the midterm elections.

Medtech's betting on the GOP in midterm elections

The medical device industry is betting on a Republican sweep of the U.S. Congress during the 2014 mid term elections, according to a MassDevice.com analysis of donations made by the industry's 10 largest political action committees.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic updates on $43B Covidien deal financing

October 24, 2014 by Brad Perriello

Medtronic issues an update on the debt financing behind its pending $43 billion acquisition of Covidien.

Medtronic updates on $43B Covidien deal financing

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp